Although several epidemiological studies have reported an association between tuberculosis (TB) and cancer development, the underlying mechanisms remain unclear [ 1 – 3 ].

Malignant pleural effusion (MPE) is one of the most common side effects of malignant tumors. Cancer cells may be found in the patient’s pleural effusion, which is mainly caused by the primary pleural malignant tumors or the metastasis of malignant …

Malignant pleural effusion (MPE) is a significant healthcare problem [ 1 ]. It is a common complication of advanced cancer, most frequently in lung and breast cancers [ 2 , 3 ], and its presence usually signifies incurable metastatic disease. The …

Pleural effusion is the buildup of fluid in the pleural space and can be caused by a range of conditions such as congestive heart failure, cancer, pneumonia, and pulmonary embolism [ 1 ]. In the United States, pleural effusion affects around 1.5 …

Pancreaticopleural fistula (PPF) is a rare complication associated with pancreatitis, particularly chronic pancreatitis, which presents a unique challenge in diagnosis and management [ 1 ]. Chronic pancreatitis, often linked to prolonged alcohol …

Pleural effusion (PE) is a common clinical manifestation in hospitalized patients and is associated with significant morbidity and mortality. It affects more than 3,000 people per million population each year [ 1 ]. Nonmalignant pleural effusions …

Immune microenvironment and immunotherapy have become the focus and frontier of tumor research, and the immune checkpoint inhibitors has provided novel strategies for tumor treatment. Malignant pleural effusion (MPE) is a common end-stage …

Dasatinib is one of the second generation tyrosine kinase inhibitors (TKI) which is approved for the treatment of patients with chronic phase CML (CP-CML) both in the front line and in the second line setting. Pleural effusion (PE) is a unique …

Malignant pleural effusion (MPE) is a common complication of advanced tumors [ 1 ] that accounts for approximately 126,800 hospital admissions per year in the USA and is the second most common cause of pleural effusion in China [ 2 , 3 ]. Lung …

Malignant pleural effusion (MPE) is a common complication of advanced tumors and significantly shortens life expectancy [ 1 ]. Approximately 125,000 hospital admissions in the USA alone are due to MPE [ 2 ]. MPE is most commonly caused by lung …

Great progress has been made in developing strategies to manage malignant pleural effusion, but these still primarily focus on optimal drainage. More research is needed to advance understanding of mechanistic drivers and develop targeted therapies.

Isolated pleural effusion is a rare manifestation of chronic graft versus host disease (cGVHD) after hematopoietic stem cell transplantation (HSCT). We herein report a 58-year-old woman presenting with massive pleural effusion approximately 1 year …

Pleural effusion is the pathologic accumulation of fluid in the pleural cavity, a closed space between the parietal and visceral pleura, due to numerous pathologic conditions with increased production (and/or a reduction in reabsorption) of …

Pleural disease, as a common disease, can be either primary, secondary to other diseases or a part of systemic disease. The incidence of pleural disease and its associated diseases (e.g., chronic lung disease, tumors, heart failure, cirrhosis …

Patients with metastatic lung adenocarcinoma (MLA) and malignant pleural effusion (MPE) without driver gene mutations have a poor prognosis. None of the standard treatment strategies is recommended for such patients. We retrospectively analyzed …